Inflammatory disease not major risk factors for severe COVID-19, focus on comorbidities urged Post author: Post published:May 3, 2024 Post category:uncategorized Severe coronavirus disease 2019 (COVID-19) outcomes in patients with immune-mediated inflammatory diseases (IMIDs). You Might Also Like The role of banana lectin in mitigating inflammatory bowel disease June 3, 2024 Polypills prove effective in reducing cardiovascular disease and mortality March 29, 2024 COVID-19 shatters decades of global health progress, slashing life expectancy April 7, 2024